Skip to content
  • Tuesday, 25 August 2026
  • 7:13 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find
Neuroscience & Brain Research

Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find

Rifan Muazin Jul 6, 2026 0

A groundbreaking study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
Neuroscience & Brain Research

Intensive Mind-Body Retreat Triggers Rapid and Measurable Changes in Brain Connectivity and Blood Chemistry Researchers at UC San Diego Find

Rifan Muazin May 7, 2026 0

A groundbreaking study led by researchers at the University of California San Diego (UCSD) has provided new, empirical evidence that…

Read More
Secrets of the Bees Reveals the Astonishing World and Urgent Plight of Our Most Vital PollinatorsScientists Solve Decade-Old Mystery of Nanoconfined Water Chemistry Through Advanced Machine Learning SimulationsTWiV 1290: Clinical Update with Dr. Daniel Griffin Delves into Infectious Disease Trends and Public Health StrategiesEngineered Entanglement: How Staple-Shaped Particles are Redefining the Future of Reversible Materials and Sustainable Construction
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ